京東健康(6618.HK)首日上市漲幅擴大至75% 市值超3800億 劉強東身價暴漲
格隆匯12月8日丨中國最大在線醫療健康平台京東健康(6618.HK)今日首日上市高開高走,午後漲幅再度擴大,一度漲75.55%至123.9港元,市值超3800億港元,碾壓阿里健康。京東集團為京東健康第一大股東,持股21.49億股,持股比例為68.73%。京東健康上市大漲,劉強東的身價隨之迎來暴漲。此前公佈的《2020福布斯中國400富豪榜》顯示,2020年劉強東以1354.5億元的身價位列中國富豪榜第17位。而在京東健康上市後,劉強東的身價已經超過了1550億元。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.